JPS6426522A - Single phase composition - Google Patents

Single phase composition

Info

Publication number
JPS6426522A
JPS6426522A JP63153665A JP15366588A JPS6426522A JP S6426522 A JPS6426522 A JP S6426522A JP 63153665 A JP63153665 A JP 63153665A JP 15366588 A JP15366588 A JP 15366588A JP S6426522 A JPS6426522 A JP S6426522A
Authority
JP
Japan
Prior art keywords
perfluoride
single phase
composition
rii
phase composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP63153665A
Other languages
English (en)
Inventor
Borugaretsuro Enriiko
Maria Karuriini Fuiritsupo
Neeri Karuro
Puratoone Edoarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enichem Sintesi SpA
Eni Tecnologie SpA
Original Assignee
Enichem Sintesi SpA
Eniricerche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20998/87A external-priority patent/IT1205174B/it
Priority claimed from IT20997/87A external-priority patent/IT1205173B/it
Application filed by Enichem Sintesi SpA, Eniricerche SpA filed Critical Enichem Sintesi SpA
Publication of JPS6426522A publication Critical patent/JPS6426522A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
JP63153665A 1987-06-23 1988-06-23 Single phase composition Pending JPS6426522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20998/87A IT1205174B (it) 1987-06-23 1987-06-23 Composizione anisotropica monofasica contenente un olio perfluorurato
IT20997/87A IT1205173B (it) 1987-06-23 1987-06-23 Composizione isotropica monofasica fuida contenente un olio perfluorurato

Publications (1)

Publication Number Publication Date
JPS6426522A true JPS6426522A (en) 1989-01-27

Family

ID=26327724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63153665A Pending JPS6426522A (en) 1987-06-23 1988-06-23 Single phase composition

Country Status (7)

Country Link
US (1) US4942179A (ja)
EP (1) EP0296661B1 (ja)
JP (1) JPS6426522A (ja)
CA (1) CA1323578C (ja)
DE (1) DE3867924D1 (ja)
ES (1) ES2030494T3 (ja)
GR (1) GR3003934T3 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6059243A (en) * 1997-02-12 2000-05-09 Nifco Inc. Vessel holder for automobile-mounted console box

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073383A (en) * 1989-04-21 1991-12-17 Affinity Biotech, Inc. Inhibiting aggregation in fluorocarbon emulsions
US6458376B1 (en) 1990-09-27 2002-10-01 Allergan, Inc. Nonaqueous fluorinated drug delivery suspensions
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5262442A (en) * 1991-12-24 1993-11-16 Alpha Therapeutic Corporation Process for rapid thawing and storage of frozen fluorocarbon emulsion, and resultant product
US5846516A (en) * 1992-06-03 1998-12-08 Alliance Pharmaceutial Corp. Perfluoroalkylated amphiphilic phosphorus compounds: preparation and biomedical applications
DE4221268C2 (de) * 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
FR2696931B1 (fr) * 1992-10-21 1994-12-30 Oreal Emulsions eau dans l'huile à phase continue fluorohydrocarbonée et utilisation de certains tensioactifs siliconés pour leur préparation.
FR2700691B1 (fr) * 1993-01-25 1995-04-07 Oreal Composition homogène à base de composés fluorés et de glycols, procédé de préparation et utilisation en cosmétique.
US5401429A (en) * 1993-04-01 1995-03-28 Minnesota Mining And Manufacturing Company Azeotropic compositions containing perfluorinated cycloaminoether
US5480914A (en) * 1994-05-06 1996-01-02 Allergan, Inc. Nonaqueous thixotropic drug delivery suspensions and methods of their use
FR2744016B1 (fr) 1996-01-30 1998-03-06 Oreal Utilisation d'extrait d'algue macroscopique comme transporteur d'oxygene
SG95579A1 (en) * 1996-03-22 2003-04-23 Bunz Montress S A Watch housing for a wrist watch
FR2771290B1 (fr) 1997-11-26 2000-02-11 Archimex Pibs Utilisation des hydrofluoroethers en tant qu'agents de dissolution de composes aromatiques pour la realisation de compositions cosmetiques
US6127320A (en) * 1998-01-19 2000-10-03 University Of Cincinnati Methods and compositions for increasing lubricity of rubber surfaces
US7829072B2 (en) * 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
FR2878746B1 (fr) * 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
DE102009026718A1 (de) 2009-06-04 2010-04-15 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung II

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3094547A (en) * 1961-02-06 1963-06-18 Minnesota Mining & Mfg Perfluoroalkylsulfonamidoalkyl esters of phosphorus acids
US3736164A (en) * 1971-07-16 1973-05-29 Air Prod & Chem Organophobic and hydrophobic surface coatings
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
DE2713498A1 (de) * 1977-03-26 1978-09-28 Bayer Ag Perfluoralkylsubstituierte phosphorsaeureester und verfahren zu ihrer herstellung
GB1599414A (en) * 1977-04-18 1981-09-30 Unilever Ltd Shampoo with anti-grease properties
FR2450105A1 (fr) * 1979-02-27 1980-09-26 Oreal Composition et procede de traitement de matieres keratiniques a base de derives fluores
FR2515198A1 (fr) * 1981-10-22 1983-04-29 Centre Nat Rech Scient Microemulsions aqueuses de fluorocarbures indefiniment stables a une temperature donnee, procede d'obtention et application a titre de transporteurs d'oxygene
CA1257828A (en) * 1984-04-16 1989-07-25 William Mccormick Perfluoro compound dispersions containing reduced amounts of surfactant and process of preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6059243A (en) * 1997-02-12 2000-05-09 Nifco Inc. Vessel holder for automobile-mounted console box

Also Published As

Publication number Publication date
EP0296661A3 (en) 1989-04-12
CA1323578C (en) 1993-10-26
DE3867924D1 (de) 1992-03-05
US4942179A (en) 1990-07-17
EP0296661B1 (en) 1992-01-22
GR3003934T3 (ja) 1993-03-16
ES2030494T3 (es) 1992-11-01
EP0296661A2 (en) 1988-12-28

Similar Documents

Publication Publication Date Title
JPS6426522A (en) Single phase composition
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
BR0012434A (pt) Composto, processo para a preparação do mesmo, uso de um composto, composição farmacêutica.
AU4218093A (en) New peptides derived from trifluoromethyl ketones, process for their preparation and the pharmaceutical compositions which contain them
SE8303911D0 (sv) Jodvinylalkoholforening och forfartande for framstellning av densamma
EP0396937A3 (en) 3-substituted polypyrrole
AU6954887A (en) Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use
NZ214122A (en) Analgesic dynorphin-like hepta and octa and nona and deca peptides
AU2001258553A1 (en) Alkyd resin emulsion
EP0193148A3 (en) 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(alkoxy-containing acyl)hydrazides
CA2080249A1 (en) Preparation of substituted piperidines
DE2965904D1 (en) 3,20-dioxo-4,9-diene-21-hydroxy-steroid compounds, process for their preparation, their use in medicines and pharmaceutical compositions containing them
AU7509481A (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
MX9206127A (es) Compuestos de acetileno
EP0450527A3 (en) N-tris(hydroxymethyl)methylfatty acid amides and cosmetic compositions containing same
IL69036A (en) Alpha-alkyl undecapentaenoic acids,pharmaceutical compositions containing the same and processes for the preparation thereof
AU3225289A (en) Novel alkanophenones
EP0298336B1 (en) Aromatic polyisocyanates, process for their preparation and their use as components of adhesives
DE59202599D1 (de) Substituierte 3,4-Dihydronaphthaline, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Verbindungen.
EP0313336A3 (en) Optically active phenylpyrimidine compounds and liquid crystal compositions containing them
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
BR9814609A (pt) Composição, processo para preparar uma composição, e, processo para polimerização por abertura de anéis oxigenados
KR910016760A (ko) 유기 구리산염을 이용하는 세프로질 합성방법
AU562168B2 (en) Organic titanium compositions for use in oil and gas wells
TW427985B (en) Process for producing 3-methyltetrahydrofuran